Skip to main content

CARACTERIZACION DE LA INESTABILIDAD GENOMICA Y LAS MUTACIONES SOMATICAS EN LINFOMA DE CELULAS DEL MANTO Y SU IMPACTO PRONOSTICO

PI17/01061

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Execution centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation

  • Bastidas-Mora, Gabriela
  • Bea, Sílvia|||0000-0001-7192-2385
  • Navarro, Alba|||0000-0002-4041-0974
  • Giné, Eva|||0000-0002-0532-1204
  • Costa, Dolors|||0000-0002-8276-3292
  • Delgado, Julio|||0000-0002-5157-4376
  • Baumann, Tycho|||0000-0003-4421-0088
  • Magnano, Laura|||0000-0002-6928-8386
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Villamor, Neus|||0000-0001-6538-4111
  • Colomer, Dolors|||0000-0001-7486-8484
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Rozman, Maria|||0000-0002-2641-1110
  • Balagué, Olga|||0000-0002-5099-3675
  • Martínez Hernández, Daniel|||0000-0001-7492-5311
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Blanes, Margarita
  • Climent, Fina|||0000-0002-4360-8388
  • Campo, Elias|||0000-0001-9850-9793
  • Wotherspoon, Andrew
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Matutes, Estella|||0000-0001-6745-7046
We describe 36 patients with splenic marginal zone lymphoma (SMZL) with transformation (SMZL-T), including 15 from a series of 84 patients with SMZL diagnosed at the Hospital Clinic of Barcelona (HCB) and 21 diagnosed with SMZL-T in other centres. In the HCB cohort, the cumulative incidence of transformation at 5 years was 15%. Predictors for transformation were cytopenias, hypoalbuminaemia, complex karyotype (CK) and both the Intergruppo Italiano Linfomi (ILL) and simplified Haemoglobin, Platelet count, lactate dehydrogenase (LDH) and extrahilar Lymphadenopathy (HPLL)/ABC scores (P < 0·05). The only independent predictor for transformation in multivariate analysis was CK [hazard ratio (HR) 4·025, P = 0·05]. Patients with SMZL-T had a significantly higher risk of death than the remainder (HR 3·89, P < 0·001). Of the 36 patients with SMZL-T, one developed Hodgkin lymphoma and 35 a diffuse large B-cell lymphoma, 71% with a non-germinal centre phenotype. The main features were B symptoms, lymphadenopathy, and high serum LDH. CK was observed in 12/22 (55%) SMZL-T and fluorescence in situ hybridisation detected abnormalities of MYC proto-oncogene, basic helix-loop-helix transcription factor (MYC), B-cell leukaemia/lymphoma 2 (BCL2) and/or BCL6 in six of 14 (43%). In all, 21 patients received immunochemotherapy, six chemotherapy, one radiotherapy and three splenectomy. The complete response (CR) rate was 61% and the median survival from transformation was 4·92 years. Predictors for a worse survival in multivariate analysis were high-risk International Prognostic Index (HR 5·294, P = 0·016) and lack of CR (HR 2·67, P < 0·001).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Unraveling the genetics of transformed splenic marginal zone lymphoma

  • Grau Vorster, Marta|||0000-0003-3779-0387
  • López, Cristina
  • Navarro, Alba|||0000-0002-4041-0974
  • Frigola, Gerard|||0000-0001-6794-6456
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Clot, Guillem|||0000-0003-2588-7413
  • Bastidas-Mora, Gabriela
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Blanes, Margarita
  • Colomer, Dolors|||0000-0001-7486-8484
  • Costa, Dolors|||0000-0002-8276-3292
  • Domingo-Domenech, Eva|||0000-0001-8907-090X
  • Enjuanes, Anna|||0000-0002-4679-6687
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Forcada, Pilar
  • Giné, Eva|||0000-0002-0532-1204
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Ramón, Olga
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Folch, Laura Vicente
  • Wotherspoon, Andrew
  • Climent, Fina|||0000-0002-4360-8388
  • Campo, Elias|||0000-0001-9850-9793
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Matutes, Estella|||0000-0001-6745-7046
  • Bea, Sílvia|||0000-0001-7192-2385
The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL) transformation are not well defined. We studied 41 patients with SMZL that eventually underwent large B-cell lymphoma transformation. Tumor material was obtained either only at diagnosis (9 patients), at diagnosis and transformation (18 patients), and only at transformation (14 patients). Samples were categorized in 2 groups: (1) at diagnosis (SMZL, n = 27 samples), and (2) at transformation (SMZL-T, n = 32 samples). Using copy number arrays and a next-generation sequencing custom panel, we identified that the main genomic alterations in SMZL-T involved TNFAIP3, KMT2D, TP53, ARID1A, KLF2, 1q gains, and losses of 9p21.3 (CDKN2A/B) and 7q31-q32. Compared with SMZL, SMZL-T had higher genomic complexity, and higher incidence of TNFAIP3 and TP53 alterations, 9p21.3 (CDKN2A/B) losses, and 6p gains. SMZL and SMZL-T clones arose by divergent evolution from a common altered precursor cell that acquired different genetic alterations in virtually all evaluable cases (92%, 12 of 13 cases). Using whole-genome sequencing of diagnostic and transformation samples in 1 patient, we observed that the SMZL-T sample carried more genomic aberrations than the diagnostic sample, identified a translocation t(14;19)(q32;q13) present in both samples, and detected a focal B2M deletion due to chromothripsis acquired at transformation. Survival analysis showed that KLF2 mutations, complex karyotype, and International Prognostic Index score at transformation were predictive of a shorter survival from transformation (P =.001; P =.042; and P =.007; respectively). In summary, SMZL-T are characterized by higher genomic complexity than SMZL, and characteristic genomic alterations that could represent key players in the transformation event.